Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

被引：0

作者：

Siegfried, Elaine C. ^{[1
,2
]}

Cork, Michael J. ^{[3
]}

Arkwright, Peter D. ^{[4
]}

Wollenberg, Andreas ^{[5
,6
]}

Eichenfield, Lawrence F. ^{[7
,8
]}

Ramien, Michele ^{[9
,10
]}

Khokhar, Faisal A. ^{[11
]}

Chen, Zhen ^{[11
]}

Zhang, Annie ^{[12
]}

Cyr, Sonya L. ^{[11
]}

机构：

[1] St Louis Univ, St Louis, MO USA

[2] Cardinal Glennon Childrens Hosp, St Louis, MO USA

[3] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England

[4] Univ Manchester, Manchester, England

[5] Ludwig Maximilians Univ Munchen, Munich, Germany

[6] UZ Brussel, VUB, Brussels, Belgium

[7] Univ Calif San Diego, San Diego, CA USA

[8] Rady Childrens Hosp, San Diego, CA USA

[9] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada

[10] Univ Calgary, Calgary, AB, Canada

[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[12] Sanofi, Cambridge, MA USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

atopic dermatitis; children; infections; safety; dupilumab;

D O I：

10.1093/bjd/ljac140.031

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

337

引用

页数：2

共 50 条

[41] T cell immunophenotypes and IgE responses in patients with moderate-to-severe atopic dermatitis receiving dupilumab [J].

Redhu, Davender ;

Francuzik, Wojciech ;

Globig, Philipp ;

Worm, Margitta .

CLINICAL AND TRANSLATIONAL ALLERGY, 2025, 15 (05)

[42] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis [J].

Marjolein S. de Bruin-Weller ;

Esther Serra-Baldrich ;

Sebastien Barbarot ;

Susanne Grond ;

Christopher Schuster ;

Helmut Petto ;

Jean-Philippe Capron ;

Afaf Raibouaa ;

Thomas Werfel .

Dermatology and Therapy, 2022, 12 :1481-1491

[43] Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis [J].

de Bruin-Weller, Marjolein S. ;

Serra-Baldrich, Esther ;

Barbarot, Sebastien ;

Grond, Susanne ;

Schuster, Christopher ;

Petto, Helmut ;

Capron, Jean-Philippe ;

Raibouaa, Afaf ;

Werfel, Thomas .

DERMATOLOGY AND THERAPY, 2022, 12 (06) :1481-1491

[44] Lebrikizumab is an effective treatment for moderate-to-severe atopic dermatitis in patients ≥60 years of age [J].

Armstrong, April ;

Zirwas, Matthew ;

Napolitano, Maddalena ;

Torres, Tiago ;

Staumont-Salle, Delphine ;

Atwater, Amber Reck ;

Dossenbach, Martin ;

Agell, Helena ;

Chen, Sherry ;

Qiao, Meihua ;

Pierce, Evangeline ;

Piruzeli, Maria Lucia Buziqui ;

Mostaghimi, Arash .

BRITISH JOURNAL OF DERMATOLOGY, 2024, 191

[45] Baseline serum biomarkers do not predict dupilumab treatment response in adults with moderate-to-severe atopic dermatitis [J].

Weidinger, Stephan ;

Beck, Lisa A. ;

de Bruin-Weller, Marjolein S. ;

Thyssen, Jacob P. ;

Kabashima, Kenji ;

Guttman-Yassky, Emma ;

Akdis, Cezmi A. ;

Chen, Zhen ;

Levit, Noah A. ;

Bastian, Mike .

BRITISH JOURNAL OF DERMATOLOGY, 2023, 188

[46] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis [J].

Fargnoli, M. C. ;

Esposito, M. ;

Ferrucci, S. ;

Girolomoni, G. ;

Offidani, A. ;

Patrizi, A. ;

Peris, K. ;

Costanzo, A. ;

Malara, G. ;

Pellacani, G. ;

Romanelli, M. ;

Amerio, P. ;

Cristaudo, A. ;

Flori, M. L. ;

Motolese, A. ;

Betto, P. ;

Patruno, C. ;

Pigatto, P. ;

Sirna, R. ;

Stinco, G. ;

Zalaudek, I. ;

Bianchi, L. ;

Boccaletti, V. ;

Cannavo, S. P. ;

Cusano, F. ;

Lembo, S. ;

Mozzillo, R. ;

Gallo, R. ;

Potenza, C. ;

Rongioletti, F. ;

Tiberio, R. ;

Grieco, T. ;

Micali, G. ;

Persechino, S. ;

Pettinato, M. ;

Pucci, S. ;

Savi, E. ;

Stingeni, L. ;

Romano, A. ;

Argenziano, G. ;

Calabrese, Giulia ;

Campanati, Anna ;

Caruso, Cristiano ;

Chello, Camilla ;

De Pasquale, Tiziana ;

Di Costanzo, Luisa ;

Dini, Valentina ;

De Pasquale, Rocco ;

Del Giglio, Micol ;

Fracassi, Giovanna .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) :507-513

[47] High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease [J].

Achten, Roselie ;

Thijs, Judith ;

van der Wal, Marlot ;

van Luijk, Chantal ;

van Luin, Matthijs ;

el Amrani, Mohsin ;

Knol, Edward ;

Delemarre, Eveline ;

Jager, Constance den Hartog ;

de Graaf, Marlies ;

Bakker, Daphne ;

de Boer, Joke ;

van Wijk, Femke ;

de Bruin-Weller, Marjolein .

CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (01)

[48] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study [J].

Berna-Rico, Emilio ;

Fiz-Benito, Esther ;

Busto-Leis, Jose Manuel ;

Servera-Negre, Guillermo ;

de Lucas-Laguna, Raul ;

Feito-Rodriguez, Marta .

DERMATOLOGY, 2024, 240 (02) :337-342

[49] Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis [J].

Guttman-Yassky, Emma ;

Weidinger, Stephan ;

Simpson, Eric ;

Gooderham, Melinda ;

Irvine, Alan ;

Spelman, Lynda ;

Silverberg, Jonathan ;

Elmaraghy, Hany ;

DeLuca-Carter, Louise ;

Piruzeli, Maria Lucia Buziqui ;

Hu, Chaoran ;

Yang, Fan Emily ;

Pierce, Evangeline ;

Bardolet, Laia ;

Thaci, Diamant .

BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 :II3-II4

[50] Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis [J].

Zinellu, Angelo ;

Sucato, Federica ;

Piras, Viviana ;

Addis, Gian Mario ;

Biondi, Gabriele ;

Montesu, Maria Antonia ;

Mangoni, Arduino A. ;

Carru, Ciriaco ;

Pirina, Pietro ;

Paliogiannis, Panagiotis ;

Fois, Alessandro G. ;

Satta, Rosanna .

JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)

← 1 2 3 4 5 →